Complement activation in cerebrospinal fluid in clinically isolated syndrome and early stages of relapsing remitting multiple sclerosis
Authors:
- 1 March 2020
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 340, 577147
Abstract
No abstract availableKeywords
Funding Information
- Linnéuniversitetet
- Forskningsrådet i Sydöstra Sverige
- Region Östergötland
- Vetenskapsrådet (2016-2075-5.1, K2013-61X-22310-01-4)
This publication has 31 references indexed in Scilit:
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteriaAnnals of Neurology, 2011
- Complement in multiple sclerosis: its role in disease and potential as a biomarkerClinical and Experimental Immunology, 2008
- Rapid magnetic resonance quantification on the brain: Optimization for clinical usageMagnetic Resonance in Medicine, 2008
- Homogeneity of active demyelinating lesions in established multiple sclerosisAnnals of Neurology, 2008
- Complement activation in Lyme neuroborreliosis — Increased levels of C1q and C3a in cerebrospinal fluid indicate complement activation in the CNSJournal of Neuroimmunology, 2007
- High sensitivity measurement of CRP and disease progression in multiple sclerosisNeurology, 2005
- Generation of iC3 at the Interface between Blood and GasScandinavian Journal of Immunology, 1992
- Intrathecal complement activation in neurological diseases evaluated by analysis of the terminal complement complexJournal of the Neurological Sciences, 1987
- Quantification of the Terminal Complement Complex in Human Plasma by an Enzyme‐Linked Immunosorbent Assay Based on Monoclonal Antibodies against a Neoantigen of the ComplexScandinavian Journal of Immunology, 1985
- Rating neurologic impairment in multiple sclerosisNeurology, 1983